bisoprolol fumarate and hydrochlorothiazide
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (bisoprolol fumarate and hydrochlorothiazide) by Bridge Therapeutics is clinical pharmacology bisoprolol fumarate and hctz have been used individually and in combination for the treatment of hypertension. Approved for the management of hypertension, hypertension. First approved in 2020.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Bisoprolol fumarate and HCTZ have been used individually and in combination for the treatment of hypertension. The antihypertensive effects of these agents are additive; HCTZ 6.25 mg significantly increases the antihypertensive effect of bisoprolol fumarate. The incidence of…
Worked on BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE at Bridge Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Thiazide Diuretic